Suppr超能文献

胰高血糖素样肽-1与大鼠肝细胞膜的结合

Glucagon-like peptide-1 binding to rat hepatic membranes.

作者信息

Villanueva-Peñacarrillo M L, Delgado E, Trapote M A, Alcántara A, Clemente F, Luque M A, Perea A, Valverde I

机构信息

Departamento Metabolismo, Nutrición y Hormonas, Fundación Jiménez Díaz, Madrid, Spain.

出版信息

J Endocrinol. 1995 Jul;146(1):183-9. doi: 10.1677/joe.0.1460183.

Abstract

We have found [125I]glucagon-like peptide (GLP)-1(7-36)amide specific binding activity in rat liver and isolated hepatocyte plasma membranes, with an M(r) of approximately 63,000, estimated by cross-linking and SDS-PAGE. The specific binding was time- and membrane protein concentration-dependent, and equally displaced by unlabelled GLP-1(7-36)amide and by GLP-1(1-36)amide, achieving its ID50 at 3 x 10(-9) M of the peptides. GLP-1(7-36)amide did not modify the basal or the glucagon (10(-8) M)-stimulated adenylate cyclase in the hepatocyte plasma membranes. These data, together with our previous findings of a potent glycogenic effect of GLP-1(7-36)amide in isolated rat hepatocytes, led us to postulate that the insulin-like effects of this peptide on glucose liver metabolism could be mediated by a type of receptor probably different from that described for GLP-1 in pancreatic B-cells or, alternatively, by the same receptor which, in this tissue as well as in muscle, uses a different transduction system.

摘要

我们在大鼠肝脏和分离的肝细胞质膜中发现了[125I]胰高血糖素样肽(GLP)-1(7-36)酰胺特异性结合活性,通过交联和SDS-PAGE估计其分子量约为63,000。特异性结合具有时间和膜蛋白浓度依赖性,未标记的GLP-1(7-36)酰胺和GLP-1(1-36)酰胺均可等量取代,肽浓度为3×10(-9)M时达到其半数抑制浓度(ID50)。GLP-1(7-36)酰胺不会改变肝细胞质膜中的基础或胰高血糖素(10(-8)M)刺激的腺苷酸环化酶。这些数据,连同我们之前在分离的大鼠肝细胞中发现的GLP-1(7-36)酰胺的强大糖原生成作用,使我们推测该肽对肝脏葡萄糖代谢的胰岛素样作用可能由一种可能不同于胰腺β细胞中描述的GLP-1受体介导,或者由相同的受体介导,在该组织以及肌肉中,该受体使用不同的转导系统。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验